Prestige Consumer Targets Improving Delivering On Demand, Considers Price Hikes As Costs Grow
Executive Summary
Around half its reported 4.7% growth to $289.3 million in latest came from price increases. Impact on supply chain continues from problems caused by novel coronavirus pandemic.
You may also be interested in...
Prestige Consumer’s International Cough/Cold Sales Offset FX Loss In Latest Results
Higher cough/cold OTC sales along with Hydralyte line and sore throat treatments bright spots in October-December offset by COVID-19 and continuing supply chain constraints.
Prestige Consumer Opens Its FY2023 With Revenue Thirst Quenched By Hydralyte International Sales
Hydralyte line has 90% share in Australia’s hydration market and accounted for a large share of firm’s overall sales growth in its latest quarter as 28.9% international sales growth to $34.5m offset flat North American results at $242.4m.
Prestige Consumer Supply Chain Prowess Helps Offset Inflationary Pressures For Record Results
After a company-record FY2022, Prestige CEO Ron Lombardi says future inflationary pressures and supply chain issues should be “manageable.”